Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Tobramycin (excluding hard capsules with powder for inhalation), (OBO), ATC J01GB01 for the period 01.12.24-30.11.26
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tobramycin (ausschl. Hartkapseln mit Pulver zur Inhalation), (OBO), ATC J01GB01 f. d. Z. 01.12.24-30.11.26
Germany · Hamburg · how to bid here →
Your path to submission
- Deadline: 5 October at 12:00 — 1 day left.
- You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
- Offer and evidence in: DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- The median procedure drew 9 bids (3,267 procedures with a bid count); 7% ended with a single bidder. Sector: median 2 bids.n = 3,267
- In this sector the buyer awards roughly every month (2862 awards, most recently June 2026) — by that rhythm the next award was due around July 2026. The last award went to Sanofi-Aventis Deutschland GmbH.n = 2,862
- 81% of this buyer's awards went to companies that had already won here before (3,321 awards since 2017, spread over 567 companies). That is well above the sector norm (62%) — newcomers have a harder time here than elsewhere.n = 3,321 awards since 2017
- 83% of the bids received came from small and medium-sized enterprises (15 procedures with a bid mix). Sector: 38%.n = 15
- The award came in at a median 79% of the estimated value (6 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 6
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 01/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,111 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 11 (from 4,142 awards).
What the buyer is looking for
DAK-Gesundheit assumes that this procedure does not fall within the scope of antitrust law due to a lack of a selection decision and therefore the non-discriminatory access of all pharmaceutical companies. It shall terminate automatically upon the entry into force of the exclusive contract for tobramycin (exclusively hard capsules with powder for inhalation), ATC J01GB01, as a result of a formal
What you must prove — eligibility criteria
From the notice of the same procedure on TED — Tenders Electronic Daily.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Abacus Medicine A/S · Kopenhagen | 184 | 2022–2026 |
| kohlpharma GmbH · Merzig | 168 | 2022–2026 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 134 | 2022–2026 |
| CC Pharma GmbH · Densborn | 131 | 2022–2025 |
| Orifarm GmbH · Leverkusen | 121 | 2015–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.